微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 1.74% | -6.45% | -49.27% | 60/157 | 0.06% | 泽璟制药 | 44.02% | 行业排名> |
| 2025-12-31 | 3.43% | -39.82% | -29.28% | 76/157 | -4.46% | 泽璟制药 | 45.29% | 行业排名> |
| 2025-09-30 | 4.85% | -35.76% | 64.97% | 65/157 | 1.31% | 兴齐眼药 | 38.62% | 行业排名> |
| 2025-06-30 | 2.94% | -33.63% | 58.06% | 64/157 | 0.3% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-03-31 | 1.86% | -24.39% | -67.37% | 59/157 | -0.34% | 翰宇药业 | 18.95% | 行业排名> |
| 2024-12-31 | 5.7% | -20.17% | -24.5% | 54/157 | -9.62% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-09-30 | 7.55% | -4.43% | 70.43% | 44/157 | 4.28% | 百利天恒 | 181.27% | 行业排名> |
| 2024-06-30 | 4.43% | -10.69% | 80.08% | 44/157 | 2.69% | 百利天恒 | 186.1% | 行业排名> |
| 2024-03-31 | 2.46% | -6.46% | -65.55% | 50/157 | 2.35% | 百利天恒 | 186.89% | 行业排名> |
| 2023-12-31 | 7.14% | 25.48% | -9.62% | 46/157 | -1% | 百利天恒 | 188.56% | 行业排名> |
| 2023-09-30 | 7.9% | 4.08% | 59.27% | 41/157 | 2.36% | 小方制药 | 41.8% | 行业排名> |
| 2023-06-30 | 4.96% | 34.42% | 88.59% | 41/157 | 1.48% | 拓新药业 | 20.51% | 行业排名> |
| 2023-03-31 | 2.63% | 24.64% | -53.78% | 46/157 | 1.37% | 拓新药业 | 19.87% | 行业排名> |
| 2022-12-31 | 5.69% | 19.79% | -25.03% | 69/157 | 0.79% | 拓新药业 | 19.91% | 行业排名> |
| 2022-09-30 | 7.59% | 22.82% | 105.69% | 48/157 | 2.86% | 小方制药 | 55.57% | 行业排名> |
| 2022-06-30 | 3.69% | 20.2% | 74.88% | 60/157 | 2.21% | 福元医药 | 25.41% | 行业排名> |
| 2022-03-31 | 2.11% | 10.47% | -55.58% | 54/157 | 1.59% | 小方制药 | 34.81% | 行业排名> |
| 2021-12-31 | 4.75% | 13.1% | -23.14% | 79/157 | 0.84% | 退市金泰 | 10.74% | 行业排名> |
| 2021-09-30 | 6.18% | 18.39% | 101.3% | 65/157 | 4.46% | ST人福 | 6.82% | 行业排名> |
| 2021-06-30 | 3.07% | 7.72% | 60.73% | 77/157 | 2.99% | 小方制药 | 71.99% | 行业排名> |
| 2021-03-31 | 1.91% | 19.38% | -54.52% | 68/157 | 2.49% | 汇宇制药 | 39.25% | 行业排名> |
| 2020-12-31 | 4.2% | 29.63% | -19.54% | 89/157 | 3.8% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-09-30 | 5.22% | -9.38% | 83.16% | 69/157 | 3.13% | 哈三联 | 27.17% | 行业排名> |
| 2020-06-30 | 2.85% | -5.94% | 78.13% | 75/157 | 4.28% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-03-31 | 1.6% | 25% | -50.62% | 59/157 | 2.23% | 中哲精化 | 45.32% | 行业排名> |
| 2019-12-31 | 3.24% | -7.95% | -43.75% | 99/157 | 2.57% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-09-30 | 5.76% | 28% | 90.1% | 61/157 | 7.58% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-06-30 | 3.03% | 0.33% | 136.72% | 69/157 | 5.02% | 奥赛康 | 35% | 行业排名> |
| 2019-03-31 | 1.28% | 36.17% | -63.64% | 76/157 | 2.45% | 奥赛康 | 28.15% | 行业排名> |
| 2018-12-31 | 3.52% | -14.36% | -21.78% | 99/157 | 7.16% | 宏源药业 | 21.91% | 行业排名> |
| 2018-09-30 | 4.5% | -12.11% | 49.01% | 73/157 | 7.21% | 奥赛康 | 9.7% | 行业排名> |
| 2018-06-30 | 3.02% | 23.77% | 221.28% | 66/157 | 4.63% | 奥赛康 | 40.69% | 行业排名> |
| 2018-03-31 | 0.94% | 16.05% | -77.13% | 79/157 | 2.57% | 信立泰 | 25.93% | 行业排名> |
| 2017-12-31 | 4.11% | 25.3% | -19.73% | 90/157 | 9.62% | 昂利康 | 15.91% | 行业排名> |
| 2017-09-30 | 5.12% | 36.17% | 109.84% | 62/157 | 8.31% | 奥赛康 | 12.08% | 行业排名> |
| 2017-06-30 | 2.44% | 37.85% | 201.23% | 76/157 | 5.56% | 一品红 | 31.62% | 行业排名> |
| 2017-03-31 | 0.81% | 39.66% | -75.3% | 65/157 | 2.1% | 丽珠集团 | 49.43% | 行业排名> |
| 2016-12-31 | 3.28% | 73.54% | -12.77% | 88/157 | 6.05% | 中哲精化 | 54.24% | 行业排名> |
| 2016-09-30 | 3.76% | 31.47% | 112.43% | 59/157 | 5.64% | 华东医药 | 7.2% | 行业排名> |
| 2016-06-30 | 1.77% | 46.28% | 205.17% | 70/157 | 3.52% | ST南新 | 81.7% | 行业排名> |
| 2016-03-31 | 0.58% | 0% | -69.31% | 70/157 | 2.69% | 德展健康 | 29.5% | 行业排名> |